We are live on
!
Find out more
KC
Karras Company Portfolio holdings
AUM
$110M
This Fund
S&P 500
This Quarter
Est. Return
+18.04%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$110M
AUM Growth
+$11.7M
(+12%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
62.11%
Holding
64
New
3
Increased
15
Reduced
40
Closed
3
Avg Time Held
1.8
quarters
Top 10 Avg Time Held
1.8
quarters
Top 20 Avg Time Held
1.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$2.19M |
| 2 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$540K |
| 3 |
Amplify International Enhanced Dividend Income ETF
IDVO
|
+$372K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$209K |
| 5 |
Copa Holdings
CPA
|
+$204K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.13M |
| 2 |
AKRE
Akre Focus ETF
AKRE
|
+$1.08M |
| 3 |
Corning
GLW
|
+$604K |
| 4 |
Salesforce
CRM
|
+$396K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$346K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.99% |
| 2 | Technology | 29.18% |
| 3 | Communication Services | 8.37% |
| 4 | Financials | 7.18% |
| 5 | Healthcare | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Invesco S&P 500 Equal Weight ETF
RSP
$97.5B
| $18.1M | 16.39% |
84,980
-1,693
| -2% | -$346K |
2025 Q4
2 quarters
|
|
2
Schwab US Dividend Equity ETF
SCHD
$110B
| $9.13M | 8.27% |
287,846
-7,646
| -3% | -$243K |
2025 Q4
2 quarters
|
|
3
Alphabet (Google) Class A
GOOGL
$4.3T
| $8.02M | 7.27% |
22,430
-199
| -0.9% | -$71.6K |
2025 Q4
2 quarters
|
|
|
4
Corning
GLW
$135B
| $7.15M | 6.48% |
27,978
-3,319
| -11% | -$604K |
2025 Q4
2 quarters
|
|
5
Broadcom
AVGO
$1.73T
| $7.12M | 6.45% |
18,851
-663
| -3% | -$266K |
2025 Q4
2 quarters
|
|
6
Apple
AAPL
$4.91T
| $4.65M | 4.21% |
16,070
-103
| -0.6% | -$29.5K |
2025 Q4
2 quarters
|
|
7
ASML
ASML
$684B
| $4.6M | 4.17% |
2,315
-200
| -8% | -$318K |
2025 Q4
2 quarters
|
|
8
Amazon
AMZN
$2.83T
| $4.28M | 3.88% |
17,948
+708
| +4% | +$178K |
2025 Q4
2 quarters
|
|
|
9
iShares Core MSCI International Developed Markets ETF
IDEV
$32.1B
| $2.93M | 2.66% |
32,916
+6,094
| +23% | +$540K |
2025 Q4
2 quarters
|
|
10
Thermo Fisher Scientific
TMO
$243B
| $2.57M | 2.33% |
5,128
+206
| +4% | +$98.9K |
2025 Q4
2 quarters
|
|
11
IBM
IBM
$214B
| $2.47M | 2.24% |
8,782
+230
| +3% | +$57.9K |
2025 Q4
2 quarters
|
|
12
JPMorgan Chase
JPM
$885B
| $2.46M | 2.23% |
7,518
-36
| -0.5% | -$11.2K |
2025 Q4
2 quarters
|
|
|
13
AstraZeneca
AZN
$247B
| $2.2M | 2% |
+11,623
| New | +$2.19M |
2026 Q2
0 quarters
|
|
14
Tesla
TSLA
$1.51T
| $2.1M | 1.9% |
4,982
-400
| -7% | -$159K |
2025 Q4
2 quarters
|
|
|
AKRE
15
Akre Focus ETF
AKRE
$4.88B
| $1.94M | 1.76% |
36,425
-20,005
| -35% | -$1.08M |
2025 Q4
2 quarters
|
|
16
Goldman Sachs
GS
$261B
| $1.52M | 1.38% |
1,506
-89
| -6% | -$86.8K |
2025 Q4
2 quarters
|
|
17
Visa
V
$724B
| $1.45M | 1.31% |
4,216
+270
| +7% | +$86.7K |
2025 Q4
2 quarters
|
|
18
Uber
UBER
$146B
| $1.42M | 1.29% |
19,723
+716
| +4% | +$52.5K |
2025 Q4
2 quarters
|
|
19
Enterprise Products Partners
EPD
$77.9B
| $1.34M | 1.21% |
36,344
-785
| -2% | -$29.6K |
2025 Q4
2 quarters
|
|
20
Allstate
ALL
$58B
| $1.28M | 1.16% |
5,393
-126
| -2% | -$27.4K |
2025 Q4
2 quarters
|
|
21
iShares MSCI USA Min Vol Factor ETF
USMV
$23.9B
| $1.24M | 1.12% |
12,850
-59
| -0.5% | -$5.6K |
2025 Q4
2 quarters
|
|
22
Cisco
CSCO
$467B
| $1.22M | 1.11% |
10,405
-623
| -6% | -$65.2K |
2025 Q4
2 quarters
|
|
23
T-Mobile US
TMUS
$159B
| $1.22M | 1.11% |
7,285
-16
| -0.2% | -$3.03K |
2025 Q4
2 quarters
|
|
|
24
Amplify International Enhanced Dividend Income ETF
IDVO
$1.43B
| $1.19M | 1.08% |
28,420
+8,792
| +45% | +$372K |
2025 Q4
2 quarters
|
|
25
Equinix
EQIX
$101B
| $1.19M | 1.07% |
1,138
-59
| -5% | -$63.2K |
2025 Q4
2 quarters
|
|
Similar funds
FI
ZS
CIM
BFA
FAOAI
IWA
SM
WPWM
Karras Company's Q2 2026 Portfolio in Review
As of Q2 2026, Karras Company held 64 positions worth $110M, up 12% from $98.6M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Karras Company's Q2 2026 filing shows 3 new, 15 increased, 40 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 11,623 shares worth $2.2M. The largest sale was Microsoft, an estimated $1.13M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 36% a quarter earlier, followed by Technology and Communication Services.
- Karras Company's largest Q2 2026 buy was AstraZeneca: 11,623 shares worth $2.2M.
- Karras Company added most to iShares Core MSCI International Developed Markets ETF in Q2 2026, an estimated $540K increase.
- Karras Company's biggest Q2 2026 reduction was Akre Focus ETF, cutting an estimated $1.08M.
- Karras Company fully exited Microsoft in Q2 2026, selling an estimated $1.13M.
- Karras Company's ten largest holdings make up 62% of its $110M portfolio in Q2 2026.
- Karras Company opened 3 new positions and closed 3 in Q2 2026.
- Karras Company's portfolio value rose 12% quarter-over-quarter to $110M.
Based on Karras Company's 13F filing for Q2 2026, filed 23 Jul 2026.